Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations

Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, sold 210 shares of common stock on April 9, 2025, to cover tax withholding obligations related to vesting restricted stock.

Summary

• On April 9, 2025, Sarah Aebersold, the Chief Human Resources Officer of BioLife Solutions Inc., sold 210 shares of the company's common stock.
• The shares were sold at a price of $20.11 per share.
• This transaction was executed under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023.
• The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
• Following the transaction, Aebersold directly owns 79,884 shares of BioLife Solutions Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and does not indicate a change in the executive's confidence in the company.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This sale appears to be for routine tax obligations.

Stakeholder Impact

• The sale is unlikely to have a significant impact on shareholders as it is a small transaction by an executive to cover tax obligations.

Key Dates

Keywords

BioLife Solutions, BLFS, Sarah Aebersold, insider trading, Form 4, stock sale, Rule 10b5-1, tax obligations, restricted stock, Chief Human Resources Officer